These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27910191)

  • 61. Mycotic keratitis due to Curvularia senegalensis and in vitro antifungal susceptibilities of Curvularia spp.
    Guarro J; Akiti T; Horta RA; Morizot Leite-Filho LA; Gené J; Ferreira-Gomes S; Aguilar C; Ortoneda M
    J Clin Microbiol; 1999 Dec; 37(12):4170-3. PubMed ID: 10565956
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
    van de Sande WW; Tavakol M; van Vianen W; Bakker-Woudenberg IA
    Med Mycol; 2010 Feb; 48(1):48-55. PubMed ID: 20055743
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species.
    Kantarcioğlu AS; Yucel A
    J Chemother; 2002 Dec; 14(6):562-7. PubMed ID: 12583546
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
    Fothergill AW; Rinaldi MG; Sutton DA
    Med Mycol; 2009 Feb; 47(1):41-3. PubMed ID: 19107637
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Case of Conjunctival Ulcer and Uveitis Caused by Acrophialophora Sp. in an Immunocompromised Patient: a Case Report and Riterature Review.
    Watanabe Y; Kobayashi T; Nakamura I; Fujita H; Shimoinaba M; Fukushima S; Miyazaki Y; Matsumoto T
    Jpn J Infect Dis; 2018 Nov; 71(6):467-469. PubMed ID: 29962481
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
    Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G
    J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Keratitis by Fusarium temperatum, a novel opportunist.
    Al-Hatmi AM; Bonifaz A; de Hoog GS; Vazquez-Maya L; Garcia-Carmona K; Meis JF; van Diepeningen AD
    BMC Infect Dis; 2014 Nov; 14():588. PubMed ID: 25388601
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Benefit of polyhexamethylene biguanide in Fusarium keratitis.
    Behrens-Baumann W; Seibold M; Hofmüller W; Walter S; Haeberle H; Wecke T; Tammer I; Tintelnot K
    Ophthalmic Res; 2012; 48(4):171-6. PubMed ID: 22710976
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
    Guilhermetti E; Takahachi G; Shinobu CS; Svidzinski TI
    Int J Dermatol; 2007 Aug; 46(8):822-6. PubMed ID: 17651164
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.
    Al-Hatmi AM; Meletiadis J; Curfs-Breuker I; Bonifaz A; Meis JF; De Hoog GS
    J Antimicrob Chemother; 2016 Apr; 71(4):953-5. PubMed ID: 26702918
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Veronaea botryosa: molecular identification with amplified fragment length polymorphism (AFLP) and in vitro antifungal susceptibility.
    Badali H; Yazdanparast SA; Bonifaz A; Mousavi B; de Hoog GS; Klaassen CH; Meis JF
    Mycopathologia; 2013 Jun; 175(5-6):505-13. PubMed ID: 23463524
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ramularia Keratitis.
    Sluch IM; Maher JH
    Cornea; 2022 Feb; 41(2):e1. PubMed ID: 34743103
    [No Abstract]   [Full Text] [Related]  

  • 76. Purpureocillium roseum sp. nov. A new ocular pathogen for humans and mice resistant to antifungals.
    Calvillo-Medina RP; Ponce-Angulo DG; Raymundo T; Müller-Morales CA; Escudero-Leyva E; Campos Guillén J; Bautista-de Lucio VM
    Mycoses; 2021 Feb; 64(2):162-173. PubMed ID: 33064905
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synergistic effect of terbinafine and amphotericin B in killing Fonsecaea nubica in vitro and in vivo.
    Zhang J; Wu X; Li M; Huang J; Yin S; Huang H; Lu C; Xi L
    Rev Inst Med Trop Sao Paulo; 2019 Jun; 61():e31. PubMed ID: 31241660
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro susceptibilities of Neoscytalidium spp. sequence types to antifungal agents and antimicrobial photodynamic treatment with phenothiazinium photosensitizers.
    Tonani L; Morosini NS; Dantas de Menezes H; Nadaletto Bonifácio da Silva ME; Wainwright M; Leite Braga GÚ; Regina von Zeska Kress M
    Fungal Biol; 2018 Jun; 122(6):436-448. PubMed ID: 29801787
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro activities of eight antifungal drugs against 104 environmental and clinical isolates of Aureobasidium pullulans.
    Najafzadeh MJ; Sutton DA; Keisari MS; Zarrinfar H; de Hoog GS; Chowdhary A; Meis JF
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5629-31. PubMed ID: 25001309
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: A systematic review.
    da Silva Hellwig AH; Heidrich D; Zanette RA; Scroferneker ML
    J Glob Antimicrob Resist; 2019 Mar; 16():108-114. PubMed ID: 30266638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.